Page not found

Molecular and Cellular Biosciences at Wake Forest University


Wake Forest University Graduate School » Molecular and Cellular Biosciences

Steven R Feldman, M.D./Ph.D.

Steven R Feldman, M.D./Ph.D.
Clinical Specialties Dermatology (general) , Psoriasis , Dermatopathology Languages Spanish Education & Training BA University of Chicago 1980 MD Duke University School of Medicine 1985 PhD Duke University 1985 Residency Dermatology North Carolina Mem Hosp 1990 Dermatopathology Med U Sc Teaching Hosps 1991 Internship Medicine Duke University Hospital 1987 Memberships American Society of Dermatopathology American Academy of Dermatology

 

Tripathi SV, Gustafson CJ, Huang KE, Feldman SR. Side effects of common acne treatments. Expert Opin Drug Saf. 2013;12(1):39-51.

 

Gustafson CJ, Watkins C, Hix E, Feldman SR. Combination therapy in psoriasis. Am J Clin Dermatol. 2013;14(1):9-25.

 

Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR. Risk of cardiovascular disorders in psoriasis patients: current and future. Am J Clin Dermatol. 2013;14(1):1-7.

 

Shutty BG, West C, Huang KE, Landis E, Dabade T, Browder B, O'Neill J, Kinney MA, Feneran AN, Taylor S, Yentzer B, McCall WV, Fleischer AB Jr, Feldman SR.Sleep disturbances in psoriasis. Dermatol Online J. 2013;19(1):1.

 

Ahn C, Gustafson C, Davis S, Feldman S. Cost-effectiveness of biologic therapies for plaque psoriasis: a systematic review [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB2.

 

Al-Dabagh A, Davis S, Feldman S. Rosacea in skin of color [abstract]. J Am Acad Dermatol. 2013;68(4 suppl 1):AB62.

 

Al-Dabagh A, Kinney M, Davis S, Feldman S. The effect of folate supplementation on methotrexate efficacy in psoriasis patients [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB181.

 

Alamdari S, Gustafson C, Lin HC, Huang K, Balkrishnan R, Davis S, Feldman S.Prevalence of psoriasis and rosacea comorbidities in the outpatient setting [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB208.

 

Cure S, Zhang F, Cawston H, Feldman SR, Tencer T, Damera V. Long-term costs of biologics in the treatment of moderate to severe psoriasis in the United States [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB205.

 

Feldman SR. Patients are often terrified of treatments [editorial]. J Dermatolog Treat. 2013;24(2):81.

 

Fenerty S, Gustafson C, Sandoval L, Feldman S. Impact of acne treatment on inflammatory bowel disease [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB5.

 

Kang S, Davis S, Feldman S. Trends in demographics and treatment for dyschromia [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB190.

 

Richardson V, West C, Gustafson C, Davis S, Feldman S. Patterns of disease and treatment of cold sores [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB135.

 

 

Yentzer BA, Ghasri P, Smith S, Fenerty SD, Davis SA, Feldman SR, Dabade TS.Acitretin for the treatment of psoriasis: an assessment of national trends [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB192.

 

 

 

 

Kaminska E, Patel I, Dabade TS, Chang J, Qureshi AA, O'Neill JL, Balkrishnan R, Feldman SR. Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk. J Dermatolog Treat. 2013;24(2):101-106.

 

Kokkonen EW, Davis SA, Lin HC, Dabade TS, Feldman SR, Fleischer AB Jr. Use of electronic medical records differs by specialty and office settings. J Am Med Inform Assoc. 2013;20(e1):e33-e38.

 

Pearce D, Sandoval LF, Feldman SR, Williford PM. The growing skin cancer problem [commentary]. Dermatol Surg. 2013;39(4):603-604.

 

Romero PC, Kinney MA, Taylor SL, Levender MM, David LR, Goldman ND, Khanna VC, Williford PM, Feldman SR. Nonmelanoma skin cancer treatment training varies across different medical specialists. J Dermatolog Treat. 2013;24(3):215-220.

 

O'Neill JL, Lee YS, Solomon JA, Patel N, Shutty B, Davis SA, Robins DN, Williford PM, Feldman SR, Pearce DJ. Quantifying and characterizing adverse events in dermatologic surgery. Dermatol Surg. 2013;39(6):872-878.

 

 

Feldman SR, Levi E, Pathak P, Kakatkar S, Blakrishnan R [sic] [Balkrishnan R].First-line use of calcipotriene/betamethasone dipropionate combination products for the treatment of plaque psoriasis is associated with lower health care utilization and cost [abstract]. Value Health. 2013;16(3):A117.

 

 

Fenerty SD, O'Neill JL, Gustafson CJ, Feldman SR. Maternal adherence factors in the treatment of pediatric atopic dermatitis [letter]. JAMA Dermatol. 2013;149(2):229-231.

 

Sandoval L, Feldman S. A young boy with perioral eruption. J Am Acad Dermatol. 2013;68(6):e159.

 

Sandoval LF, Davis SA, Feldman SR. Dermatologists' knowledge of and preferences regarding topical steroids [abstract]. J Invest Dermatol. 2013;133(Suppl 1):S44.

 

Tan X, Al-Dabagh A, Balkrishnan R, Davis SA, Feldman S. Medication adherence, healthcare costs and utilization associated with acne drugs in the United States [abstract]. J Invest Dermatol. 2013;133(Suppl 1):S161.

 

Al-Dabagh A, Davis SA, Kinney MA, Huang K, Feldman SR. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA. Am J Clin Dermatol. 2013;14(3):155-161.

 

Davis SA, Feldman SR. Combination therapy for psoriasis in the United States. J Drugs Dermatol. 2013;12(5):546-550.

 

Martin SL, McGoey ST, Bebo BF Jr, Feldman SR. Patients' educational needs about topical treatments for psoriasis. J Am Acad Dermatol. 2013;68(6):E163-E168.

 

Taheri A, Feldman SR. Can light-field photography ease focusing on the scalp and oral cavity?. Skin Res Technol. 2013;19(3):288-290.

 

Tan X, Al-Dabagh A, Davis SA, Lin HC, Balkrishnan R, Chang J, Feldman SR.Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Am J Clin Dermatol. 2013;14(3):243-251.

 

Alamdari HS, Gustafson CJ, Davis SA, Huang W, Feldman SR. Psoriasis and cardiovascular screening rates in the United States. J Drugs Dermatol. 2013;12(1):e14-19.

 

 

Davis SA, Yentzer BA, Feldman SR. Acitretin prescribing patterns in women of childbearing potential. J Drugs Dermatol. 2013;12(7):799-802.

 

Sandoval LE, Davis SA, Feldman SR. Dermatologists' knowledge of and preferences regarding topical steroids. J Drugs Dermatol. 2013;12(7):786-789.

 

Ahn CS, Gustafson CJ, Sandoval LF, Davis SA, Feldman SR. Cost effectiveness of biologic therapies for plaque psoriasis. Am J Clin Dermatol. 2013;14(1):315-326.

 

Ahn CS, Awadalla F, Huang KE, Yentzer B, Dabade TS, Feldman SR. Patterns of vitamin D analog use for the treatment of psoriasis. J Drugs Dermatol. 2013;12(8):906-910.

 

Ahn C, Davis SA, Dabade TS, Fleischer AB Jr, Feldman SR. Services available and their effectiveness. Dermatol Clin. 2012;30(1):19-37.

 

Barnes LE, Levender MM, Fleischer AB Jr, Feldman SR. Quality of life measures for acne patients. Dermatol Clin. 2012;30(2):293-300.

 

Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR. The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence. 2012;6():127-135.

 

Hsu S, Papp KA, Lebwohl MG, Bagel J, Blauvelt A, Duffin KC, Crowley J, Eichenfield LF, Feldman SR, Fiorentino DF, Gelfand JM, Gottlieb AB, Jacobsen C, Kalb RE, Kavanaugh A, Korman NJ, Krueger GG, Michelon MA, Morison W, Ritchlin CT, Gold LS. Consensus guidelines for the management of plaque psoriasis. Arch Dermatol. 2012;148(1):95-102.

 

Mudigonda T, Dabade TS, Feldman SR. A review of protocols for 308 nm excimer laser phototherapy in psoriasis. J Drugs Dermatol. 2012;11(1):92-97.

 

Vogel SA, Yentzer B, Davis SA, Feldman SR, Cordoro KM. Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol. 2012;148(1):66-71.

 

Wilson RL, Yentzer BA, Isom SP, Feldman SR, Fleischer AB Jr. How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis. J Dermatolog Treat. 2012;23(1):65-69.

 

Mudigonda T, Dabade TS, Feldman SR. A review of targeted ultraviolet B phototherapy for psoriasis. J Am Acad Dermatol. 2012;66(4):664-672.

 

Levender MM, Davis SA, Kwatra SG, Williford PM, Feldman SR. Use of topical antibiotics as prophylaxis in clean dermatologic procedures. J Am Acad Dermatol. 2012;66(3):445-451.

 

Glenn C, McMichael A, Feldman SR. Measuring patient satisfaction changes patient satisfaction [editorial]. J Dermatolog Treat. 2012;23(2):81-82.

 

Nolan BV, Levender MM, Davis SA, Feneran AN, Fleischer AB Jr, Feldman SR.Trends in the use of topical over the counter products in the management of dermatologic disease in the United States. Dermatol Online J. 2012;18(2):1.

 

Bolaji RS, Dabade TS, Gustafson CJ, Davis SA, Krowchuk DP, Feldman SR.Treatment of impetigo: oral antibiotics most commonly prescribed. J Drugs Dermatol. 2012;11(4):489-494.

 

Schroeder RE, Kaplan SG, Feldman SR. The effects of acne on self-esteem among adolescents. Cosmet Dermatol. 2012;25(2):66-70.

 

Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11(4):466-473.

 

Draelos Z, Saenz AA, Feldman SR, Butners V. Long-term safety of ketoconazole foam 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB56.

 

Feldman SR, Preston NJ, Fried RG, Caveney SW. Subjects' experiences using adapalene-BPO gel in the treatment of acne vulgaris [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB19.

 

Feneran A, Kaufman B, Feldman S, Dabade T. Retinoid plus antimicrobial combination treatments for acne [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB18.

 

Koch S, Levender MM, Feldman SR. Review of the effect of race/ethnicity on medication adherence [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB61.

 

Koelblinger P, Davis S, Feldman S, Dabade T. Skin manifestations of outpatient adverse drug events in the United States: a national analysis [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB5.

 

Landis E, Feneran AN, Levender MM, Davis SA, Feldman SR. Oral contraceptives may be underutilized in the treatment of acne in the United States [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB17.

 

Mudigonda P, Feneran A, Feldman S, Mudigonda T. Interleukin-17, interleukin-23, and psoriasis: current prospects [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB195.

 

Mudigonda T, Feldman S, Dabade T. 308-nm excimer laser versus nontargeted phototherapy for localized psoriasis: a review [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB181.

 

Mudogonda T, Feldman S, Dabade T. A review of protocols for 308-nm excimer laser phototherapy in psoriasis [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB182.

 

Mudigonda T, Feldman S, Dabade T. A review of targeted UVB phototherapy for psoriasis [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB183.

 

Nolan BV, Fleischer AB Jr, Feneran AN, Levender MM, Davis SA, Feldman SR.Trends in the use of topical over the counter products in the management of dermatologic disease in the United States [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB173.

 

Ntuen E, Qureshi A, Patel I, O'Neill J, Balkrishnan R, Feldman S, Dabade T.Comparing the lifetime risks of TNF-a inhibitor use in patients with severe psoriasis to common benchmarks of risk [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB188.

 

Prince G, O'Neill J, Davis S, Feldman S. Children's eczema action plan [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB69.

 

Yentzer B, Clark A, Wood A, O'Neill J, Williams L, Sagransky M, Feldman S. An internet-based survey and contest: a novel method for improving acne outcomes [abstract]. J Am Acad Dermatol. 2012;66(4 Suppl):AB14.

 

Kosari P, Feldman SR. Letter: Treatment-resistant pyoderma gangrenosum. Dermatol Online J. 2012;18(4):8.

 

Balkrishnan R, Kulkarni AS, Anderson RT, Narahari S, Landis E, Feldman SR.Psychometrics of the actinic keratosis risk questionnaire: a risk assessment instrument [abstract]. Value Health. 2012;15(4):A12.

 

Feldman SR. Customizing acne regimens for optimal outcomes [editorial]. J Drugs Dermatol. 2012;11(6 Suppl):S6.

 

Feldman SR. A novel approach to increasing patient outcomes and adherence. J Drugs Dermatol. 2012;11(6 Suppl):S14-S17.

 

 

Lin HC, Clodfelter RP, Lee CH, Balkrishnan R, Feldman SR. Acne drug therapy and the development of comorbid major depressive disorder in the United States [abstract]. Value Health. 2012;15(4):A81.

 

Lin HC, Lucas PT, Feldman SR, Balkrishnan R. Medication use and associated health care outcomes and costs for patients with psoriasis in the United States. J Dermatolog Treat. 2012;23(3):196-202.

 

Narahari S, Gustafson CJ, Feldman SR. What's new in antibiotics in the management of acne?. G Ital Dermatol Venereol. 2012;147(3):227-238.

 

Shutty B, West C, Pellerin M, Feldman S. Apremilast as a treatment for psoriasis. Expert Opin Pharmacother. 2012;13(12):1761-1770.

 

Feldman SR, Matheson R, Bruce S, Grande K, Markowitz O, Kempers S, Brundage T, Wyres M. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials. Am J Clin Dermatol. 2012;13(4):261-271.

 

Luersen K, Davis SA, Kaplan SG, Abel TD, Winchester WW, Feldman SR. Sticker charts: a method for improving adherence to treatment of chronic diseases in children. Pediatr Dermatol. 2012;29(4):403-408.

 

Feldman SR, Fried RG, Herndon JH Jr, Johnson L, Preston N, Gottschalk RW, Caveney SW. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris. J Drugs Dermatol. 2012;11(8):919-925.

 

Kwatra SG, Dabade TS, Gustafson CJ, Feldman SR. JAK inhibitors in psoriasis: a promising new treatment modality. J Drugs Dermatol. 2012;11(8):913-918.

 

Landis ET, Levender MM, Davis SA, Feneran AN, Gerancher KR, Feldman SR.Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey. J Dermatolog Treat. 2012;23(4):272-277.

 

Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012;11(8):957-962.

 

Arrington EA, Patel NS, Gerancher K, Feldman SR. Combined oral contraceptives for the treatment of acne: a practical guide. Cutis. 2012;90(2):83-90.

 

Feldman SR. Let's not presuppose that patients take their medications [editorial]. J Dermatolog Treat. 2012;23(5):317.

 

Huynh M, Lee AD, Miller LM, Davis S, Feldman SR, McMichael A. Patients' satisfaction with dermatology residents. South Med J. 2012;105(10):520-523.

 

Pearce DJ, Feldman SR, Williford PM. We know how much Mohs is done, but is it appropriate? [commentary]. Dermatol Surg. 2012;38(9):1435-1436.

 

Sagransky MJ, Pichardo-Geisinger RO, Munoz-Ali D, Feldman SR, Mora DC, Quandt SA. Pachydermodactyly from repetitive motion in poultry processing workers: a report of 2 cases. Arch Dermatol. 2012;148(8):925-928.

 

Mudigonda P, Mudigonda T, Feneran AN, Alamdari HS, Sandoval L, Feldman SR.Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. Dermatol Online J. 2012;18(10):1.

 

Haushalter K, Murad EJ, Dabade TS, Rowell R, Pearce DJ, Feldman SR. Efficacy of low-dose acitretin in the treatment of psoriasis. J Dermatolog Treat. 2012;23(6):400-403.

 

Mudigonda T, Dabade TS, West CE, Feldman SR. Therapeutic modalities for localized psoriasis: 308-nm UVB excimer laser versus nontargeted phototherapy. Cutis. 2012;90(3):149-154.

 

Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9(10):1263-1271.

 

Feldman SR. Reaching for better understanding across the globe [editorial]. J Dermatolog Treat. 2012;23(6):397.

 

Kim IH, West CE, Kwatra SG, Feldman SR, O'Neill JL. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol. 2012;13(6):365-374.

 

Feldman SR, Sandoval L. Practice gap in patient education [commentary]. Arch Dermatol. 2012;148(11):1255-1256.

 

Kwatra SG, Feldman SR. A dermatologist's dilemma: treatment failure or failure to treat? [editorial]. Cutis. 2012;90(5):219-220.

 

Lin HC, Lee CH, Balkrishnan R, Feldman SR. Acne drug therapy and the development of comorbid inflammatory bowel disease in the United States [abstract]. Value Health. 2012;15(7):A635.

 

 

Dunn LK, O'Neill JL, Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011;17(1):1.

 

Spears CR, Nolan BV, O'Neill JL, Arcury TA, Grzywacz JG, Feldman SR.Recruiting underserved populations to dermatologic research: a systematic review. Int J Dermatol. 2011;50(4):385-395.

 

Alikhan A, Karan A, Feldman SR, Maibach HI. Seasonal variations in dermatology manuscript submission [letter]. J Dermatolog Treat. 2011;22(1):60.

 

Anis AH, Bansback N, Sizto S, Gupta SR, Willian MK, Feldman SR. Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States. J Dermatolog Treat. 2011;22(2):65-74.

 

Feldman SR, Tan J, Dirschka T, Poulin Y. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions [abstract]. J Am Acad Dermatol. 2011;64(2 Suppl 1):AB15.

 

Feldman S, Li G, Wyres M, Van Syoc M, Kempers S. Calcipotriene foam is an effective treatment for plaque-type psoriasis [abstract]. J Am Acad Dermatol. 2011;64(2 Suppl 1):AB146.

 

Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64(5):936-949.

 

Persad P, Levender MM, Feldman SR. Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population. Dermatol Online J. 2011;17(2):article 10.

 

Tran B, Feldman SR. Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market. J Dermatolog Treat. 2011;22(1):18-26.

 

Vogel S, Fleischer A, Yentzer B, Cordoro K, Feldman S. Outpatient visits by children with psoriasis in the United States: 1979 to 2007 [abstract]. J Am Acad Dermatol. 2011;64(2 Suppl 1):AB131.

 

Yentzer BA, Gosnell AL, Clark AR, Pearce DJ, Balkrishnan R, Camacho FT, Young TA, Fountain JM, Fleischer AB Jr, Feldman SR, et al. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris [letter]. J Am Acad Dermatol. 2011;64(4):793-795.

 

O'Neill J, Pearce DJ, Lee Y, Solomon JA, Williford P, Robins DN, Feldman SR.Quantifying and characterizing adverse events in dermatologic surgery [abstract]. J Invest Dermatol. 2011;131(Suppl 1):S42.

 

Yentzer BA, Wood AA, Sagransky MJ, O'Neill JL, Clark AR, Williams LL, Feldman SR. An internet-based survey and contest: a novel method for improving acne outcomes [abstract]. J Invest Dermatol. 2011;131(Suppl 1):S84.

 

Augustin M, Feldman S, Wolbring F, Szapary P, Schenkel B. Cost effectiveness--analysis of therapy with ustekinumab versus etanercept in patients with moderate to severe plaque psoriasis based on the ACCEPT study [abstract] [German]. J Dtsch Dermatol Ges. 2011;9(Suppl 1):191.

 

Dabade TS, Feldman SR. A consideration when interpreting outpatient data [letter]. J Am Acad Dermatol. 2011;64(6):1180-1181.

 

 

 

Dabade TS, Feldman SR. We must think outside the box to understand nonadherence [commentary]. Pediatr Dermatol. 2011;28(3):353.

 

Feldman SR, Chen DM. How patients experience and manage dryness and irritation from acne treatment. J Drugs Dermatol. 2011;10(6):605-608.

 

Feldman SR, Tan J, Poulin Y, Dirschka T, Kerrouche N, Manna V. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am Acad Dermatol. 2011;64(6):1085-1091.

 

 

Martin S, Feldman SR, Augustin M, Szapary P, Schenkel B. Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis. J Dermatolog Treat. 2011;22(3):138-143.

 

Feldman SR. It isn't a perfect world [editorial]. J Dermatolog Treat. 2011;22(1):1.

 

 

Feneran AN, Kaufman WS, Dabade TS, Feldman SR. Retinoid plus antimicrobial combination treatments for acne. Clin Cosmet Investig Dermatol. 2011;4():79-92.

 

Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JYM, Lebwohl M, Leonardi CL, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137-174.

 

Staidle JP, Dabade TS, Feldman SR. A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother. 2011;12(13):2041-2054.

 

Ghasri P, Yentzer BA, Dabade TS, Feldman SR. Acitretin for the treatment of psoriasis: an assessment of national trends. J Drugs Dermatol. 2011;10(8):873-877.

 

Gustafson CJ, Taylor SL, Feldman SR. Usage of complementary and alternative medicine for management of skin disease. J Dermatolog Treat. 2011;22(5):306-308.

 

Smith SF, Feldman SR. Tattoo sites and psoriasis. J Drugs Dermatol. 2011;10(10):1199-1200.

 

Yentzer BA, Wood AA, Sagransky MJ, O'Neill JL, Clark AR, Williams LL, Feldman SR. An internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011;147(10):1223-1224.

 

Goldberg JL, Dabade TS, Davis SA, Feldman SR, Krowchuk DP, Fleischer AB.Changing age of acne vulgaris visits: another sign of earlier puberty?. Pediatr Dermatol. 2011;28(6):645-648.

 

Lapolla WJ, Levender MM, Davis SA, Yentzer BA, Williford PM, Feldman SR.Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications. Dermatol Surg. 2011;37(10):1427-1433.

 

Dunn LK, Gaar LR, Yentzer BA, O'Neill JL, Feldman SR. Acitretin in dermatology: a review. J Drugs Dermatol. 2011;10(7):772-782.

 

Glenn C, Feldman SR. Letter: Tetracycline-induced hepatotoxicity. Dermatol Online J. 2011;17(12):14.

 

Ou HT, Feldman SR, Balkrishnan R. Medication adherence to topical medications and healthcare expenditures in Medicaid-enrolled child with atopic dermatitis [abstract]. Value Health. 2011;14(3):A57-A58.

 

Patel P, Lin HC, Feldman SR, Fleischer AB, Nahata M, Balkrishnan R. Medication choice and associated health care outcomes and costs for patients with acne and acne related conditions in the United States [abstract]. Value Health. 2011;14(3):A57.

 

Wu J, Adolph MD, Feldman SR, Balkrishnan R. Differences in patient satisfaction with primary care and specialty care [abstract]. Value Health. 2011;14(3):A110.

 

Feneran AN, Dabade TS, Feldman SR. Treating rare fungal infections: Majocchi's granuloma. Dermatologist. 2011;19(2):32-35.

 

Feneran AN, Feldman SR. Treating rare fungal infections: cryptococcosis. Dermatologist. 2011;19(10):34-38.

 

Luersen K, Feldman SR. Increasing treatment compliance with sticker charts. Dermatologist. 2011;19(11):42-43.

 

Persad P, Levender MM, Feldman SR. A review of internal malignancy risks associated with the treatment of psoriasis. Dermatologist. 2011;19(6):32-36.

 

Drugs/therapeutic agents pharm, health services, research/outc